• Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests.
  • Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs.
  • We will collaborate with partners, create branded products and identify complementary businesses which support our objective of continuing to grow as a respected and profitable healthcare company.
  • Our Values include meeting all current and future regulatory, quality and environmental standards appropriate for our industry and the countries in which we operate.

The mortality rate of severe sepsis is estimated at 28-50%, six times higher than from acute myocardial infarction, with annual costs in Europe alone of €7.6 billion

Sepsis is an acute systemic response to infection, often with fever, tachycardia, hypotension, increased respiratory rate and abnormal white cell counts. Left unchecked, it can progress to severe sepsis and ultimately multiple organ failure and death.
There is an urgent need for a marker that can predict the future onset of severe sepsis to allow early and appropriate clinical intervention.

As part of our continuing programme aimed at the identification and acquisition of novel markers, and the delivery of new patented tests to our partners, in 2009 we signed a global agreement with Hansa Medical, of Lund, Sweden, for exclusive rights to a diagnostic assay for Heparin Binding Protein (HBP) as a promising marker for severe sepsis and related conditions. Under the terms of the agreement, Axis-Shield will develop tests for HBP and seek commercial partners to incorporate the assay onto the menus of high-throughput laboratory systems.

Our new HBP assay was launched in 2012 and data to date suggest the test has better performance than existing markers for identification of those patients at risk of developing severe sepsis.

For more information please visit our HBP product page or see www.heparinbindingprotein.com

Axis-Shield at a Glance

A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories.

› More about our tests

Focus on Homocysteine

As a general marker of overall health status, few tests carry greater predictive weight than Homocysteine. The amount of Homocysteine in your blood is one of the best independent indicators of how healthy you are.


› Axis-Shield Homocysteine assays

© Axis-Shield plc 2011. All rights reserved. Registered in Scotland No. SC145200 - Sitemap | Terms-of-Use | Accessibility | Disclaimer
Luna Place, The Technology Park, Dundee, DD2 1XA, Scotland.
Diagnostics for the laboratory & the point of care in areas of clinical need including diabetes, cardiovascular & neurodegenerative disease, rheumatoid arthritis & infectious disease.